Effect of ketoprofen and tolfenamic acid on intravenous pharmacokinetics of ceftriaxone in sheep
Özet
In this study, the pharmacokinetics of ceftriaxone (40 mg/kg) was determined following a single intravenous (IV) administration of ceftriaxone alone and co-administration with ketoprofen (3 mg/kg) or tolfenamic acid (2 mg/kg) in sheep. Eight healthy Akkaraman sheep (2.4 ± 0.3 years and 44 ± 4 kg of body weight) were used. The study was carried out according to the longitudinal design in three periods with a 15-day washout period between administrations. In the first period, sheep received ceftriaxone alone via an IV injection. In the second and third periods, the same sheep received ceftriaxone in combination with ketoprofen and tolfenamic acid, respectively. Plasma concentrations of ceftriaxone were assayed by high-performance liquid chromatography and analyzed using non-compartmental analysis. Following the administration of ceftriaxone alone, the elimination half-life (t1/2ʎz), area under the plasma concentration–time curve from zero (0) hours to infinity (∞) (AUC0-∞), total clearance (ClT), and volume of distribution at steady state were 1.42 h, 182.41 h*µg/ml, 0.22 L/h/kg, and 0.17 L/kg, respectively. While ketoprofen and tolfenamic acid significantly increased the t1/2ʎz and AUC0-∞ of ceftriaxone, they significantly reduced the ClT. Ceftriaxone (40 mg/kg, IV) in concurrent use with ketoprofen and tolfenamic acid can be administrated at the 12 h dosing intervals to maintain T> minimum inhibitory concentration (MIC) values above 60% in the treatment of infections caused by susceptible pathogens with the MIC value of ≤0.75 and ≤1 μg/mL, respectively, in sheep with an inflammatory condition. © 2021 John Wiley & Sons Ltd.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Cetin, Gul | |
| dc.contributor.author | Durna Corum, Duygu | |
| dc.contributor.author | Corum, Orhan | |
| dc.contributor.author | Atik, Orkun | |
| dc.contributor.author | Coskun, Devran | |
| dc.contributor.author | Uney, Kamil | |
| dc.date.accessioned | 2026-10-18T20:28:13.573623169Z | |
| dc.date.available | 2026-10-18T20:28:13.573623169Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | In this study, the pharmacokinetics of ceftriaxone (40 mg/kg) was determined following a single intravenous (IV) administration of ceftriaxone alone and co-administration with ketoprofen (3 mg/kg) or tolfenamic acid (2 mg/kg) in sheep. Eight healthy Akkaraman sheep (2.4 ± 0.3 years and 44 ± 4 kg of body weight) were used. The study was carried out according to the longitudinal design in three periods with a 15-day washout period between administrations. In the first period, sheep received ceftriaxone alone via an IV injection. In the second and third periods, the same sheep received ceftriaxone in combination with ketoprofen and tolfenamic acid, respectively. Plasma concentrations of ceftriaxone were assayed by high-performance liquid chromatography and analyzed using non-compartmental analysis. Following the administration of ceftriaxone alone, the elimination half-life (t1/2ʎz), area under the plasma concentration–time curve from zero (0) hours to infinity (∞) (AUC0-∞), total clearance (ClT), and volume of distribution at steady state were 1.42 h, 182.41 h*µg/ml, 0.22 L/h/kg, and 0.17 L/kg, respectively. While ketoprofen and tolfenamic acid significantly increased the t1/2ʎz and AUC0-∞ of ceftriaxone, they significantly reduced the ClT. Ceftriaxone (40 mg/kg, IV) in concurrent use with ketoprofen and tolfenamic acid can be administrated at the 12 h dosing intervals to maintain T> minimum inhibitory concentration (MIC) values above 60% in the treatment of infections caused by susceptible pathogens with the MIC value of ≤0.75 and ≤1 μg/mL, respectively, in sheep with an inflammatory condition. © 2021 John Wiley & Sons Ltd. | |
| dc.description.sponsorship | Funding text 1: This study was supported by The Coordination of Scientific Research Projects, University of Erzincan Binali Yıldırım, Turkey (Project No. TSA‐2019‐522). The abstract form of study was presented as oral presentation to 2th International Health Sciences and Innovation Congress, Ankara, Turkey, September 27‐28, 2020. ; Funding text 2: This study was supported by The Coordination of Scientific Research Projects, University of Erzincan Binali Y?ld?r?m, Turkey (Project No. TSA-2019-522). The abstract form of study was presented as oral presentation to 2th International Health Sciences and Innovation Congress, Ankara, Turkey, September 27-28, 2020. | |
| dc.identifier.doi | 10.1111/jvp.13001 | |
| dc.identifier.eissn | 1365-2885 | |
| dc.identifier.endpage | 951 | |
| dc.identifier.issn | 0140-7783 | |
| dc.identifier.issue | 6 | |
| dc.identifier.pmid | 34312894 | |
| dc.identifier.scopus | 2-s2.0-85111259601 | |
| dc.identifier.startpage | 945 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/13386 | |
| dc.identifier.volume | 44 | |
| dc.identifier.wos | WOS:000678980300001 | |
| dc.language.iso | en | |
| dc.publisher | John Wiley and Sons Inc | |
| dc.relation.ispartof | Journal of Veterinary Pharmacology and Therapeutics | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | ceftriaxone | |
| dc.subject | ketoprofen | |
| dc.subject | pharmacokinetics | |
| dc.subject | sheep | |
| dc.subject | tolfenamic acid | |
| dc.subject | Animals | |
| dc.subject | Area Under Curve | |
| dc.subject | Half-Life | |
| dc.subject | Injections, Intravenous | |
| dc.subject | ortho-Aminobenzoates | |
| dc.subject | tolfine | |
| dc.subject | vilprofen | |
| dc.subject | anthranilic acid derivative | |
| dc.subject | Akkaraman sheep | |
| dc.subject | animal experiment | |
| dc.subject | area under the curve | |
| dc.subject | Article | |
| dc.subject | concentration response | |
| dc.subject | controlled study | |
| dc.subject | drug blood level | |
| dc.subject | drug clearance | |
| dc.subject | drug effect | |
| dc.subject | elimination half-life | |
| dc.subject | female | |
| dc.subject | high performance liquid chromatography | |
| dc.subject | longitudinal study | |
| dc.subject | minimum inhibitory concentration | |
| dc.subject | nonhuman | |
| dc.subject | plasma concentration-time curve | |
| dc.subject | single drug dose | |
| dc.title | Effect of ketoprofen and tolfenamic acid on intravenous pharmacokinetics of ceftriaxone in sheep | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 7 | |
| rdl.citation.wos | 7 | |
| rdl.department | Department of Pharmacology, Faculty of Pharmacy, University of Erzincan Binali Yıldırım, Erzincan, Turkey. | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
